News

Tiny ‘live’ brain models are being used at The University of Queensland to study a condition causing high-functioning young people with Down Syndrome to suddenly regress.

On International Womens’ Day, we asked AIBN’s Associate Professor Joy Wolfram what advice she would give to her 16-year-old self if she could mentor a younger Joy.

The success of mRNA vaccines and cell therapies has highlighted the importance of biotechnology, and AIBN has helped kick-start the process for establishing a biomanufacturing ecosystem for Queensland.

Almost 30 AIBN Scientists submitted entries to the 2021 AIBN image contest, highlighting the role imagination and creativity play in scientific research.

Studying tiny ‘live’ models of the human brain has helped researchers understand its ageing and find a key to potential treatments neurodegenerative diseases.

Cracked phone screens could become a thing of the past thanks to breakthrough research.

A new generation of cheap, sustainable and efficient solar cells is a step closer.

Professor Trent Munro has joined the Advisory Board of Macrobiome Therapeutics.

An antiviral surface coating technology sprayed on face masks could provide an extra layer of protection against COVID-19 and the flu.

AIBN Professor Trent Munro is leading a team to develop, test and manufacture specific therapeutics in Australia, including for use against COVID-19.

The UQ Foundation Research Excellence Awards (FREA) scheme is a means by which the University recognises demonstrated excellence and promise of future success in research.

Researchers studying ageing in tiny ‘live’ models of the human brain have found a key to potential treatments for Alzheimer’s and other neurodegenerative diseases.

Improving a “trial-and-error approach’’ to epilepsy treatment is the aim of research that encompasses stem cells, artificial intelligence, brain organoids and drug screening.

Researchers could herald the the next generation of electronics with silicon-based technology.

High school students have received hands-on experience developing nanomedicines using state of the art technology.

Needle-free technology, originally developed at the AIBN, has been used to administer a COVID-19 vaccine candidate to successfully protect mice, demonstrating the potential of non-invasive delivery.

A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.

Faster-charging and more sustainable batteries with a life up to three times greater than lithium ion are being built with technology developed at AIBN.

University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.

On International Womens’ Day, we asked AIBN’s Dr Nasim Amiralian what advice she would give to her 16-year-old self, if she could mentor a younger Nasim.